Interactions of adult neural stem cells (NSCs) with supportive vasculature appear critical for their maintenance and function, although the molecular details are still under investigation. Neurotrophin (NT)-3 belongs to the NT family of trophic factors, best known for their effects in promoting neuronal survival. Here we show that NT-3 produced and secreted by endothelial cells of brain and choroid plexus capillaries is required for the quiescence and long-term maintenance of NSCs in the mouse subependymal niche. Uptake of NT-3 from irrigating vasculature and cerebrospinal fluid (CSF) induces the rapid phosphorylation of endothelial nitric oxide (NO) synthase present in the NSCs, leading to the production of NO, which subsequently acts as a cytostatic factor. Our results identify a novel interaction between stem cells and vasculature/CSF compartments that is mediated by an unprecedented role of a neurotrophin and indicate that stem cells can regulate their own quiescence in response to endothelium-secreted molecules.
INTRODUCTION
Neurotrophin-3 (NT-3; encoded by the Ntf3 gene) belongs to the neurotrophin family of closely related neurotrophic factors, which also includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and NT-4/5. Neurotrophins were first identified as survival factors for developing neurons, but they can also regulate cell fate decisions, axon and dendrite growth, synaptic function and plasticity, or neuronal differentiation during embryogenesis and in adulthood. Neurotrophins activate tyrosine kinase receptors of the tropomyosin-related kinase (Trk) family, engaging different intracellular signaling pathways, and can also interact with the p75 neurotrophin receptor, a member of the tumor necrosis factor receptor superfamily (Reichardt, 2006) . Although neurotrophin actions are characteristically restricted to the nervous system, initial studies on the phenotype of Ntf3 mutant mice demonstrated that NT-3 was also implicated in cardiac development (Donovan et al., 1996) . Despite these early findings outside the neural tissue, expression of NT-3 by endothelial cells and its potential functions in the context of vascular biology have begun to emerge only recently (Cristofaro et al., 2010) .
The murine subependymal zone (SEZ), adjacent to the lateral ventricle ependymal wall, is a very active germinal niche in which a continual process of progenitor cell replication and differentiation results in the persistent production of olfactory bulb (OB) interneurons and corpus callosum (CC) oligodendrocytes (Zhao et al., 2008) . The lifelong generation of these cells is supported by radial glia-derived B1 cells, which express the astrocytic antigen glial fibrillary acidic protein (GFAP) and stem cell markers such as Nestin, Id1 and Sox2 and act as neural stem cells (NSCs). Moreover, when activated, B1 cells divide slowly and can hence retain bromodeoxyuridine (BrdU) for several weeks (Nam and Benezra, 2009; Maslov et al., 2004; Pastrana et al., 2009) . B1 cells retain the elongated polarized morphology of their radial glia predecessors and span between the ependyma, which line the ventricle, and the network of blood vessels that irrigate the SEZ niche. Moreover, the thin apical process of B1 cells intercalates among multiciliated ependymocytes and ends in a single nonmotile primary cilium that can act as a sensor of molecules present in the ventricular CSF (Falcã o et al., 2012; Mirzadeh et al., 2008; Shen et al., 2008; Tavazoie et al., 2008) . This characteristic morphology correlates with experimental evidence indicating that blood vessels and the CSF constitute regulated sources of soluble signals acting on NSCs. However, although some vasculature-derived signals have been shown to activate NSCs (Calabrese et al., 2007; Ramírez-Castillejo et al., 2006) , the potential involvement of vascular signals in promoting NSC quiescence and long-term maintenance is largely unknown.
NT-3 is widely expressed during fetal development but its synthesis becomes restricted to specific locations in the postnatal brain (Maisonpierre et al., 1990; Vigers et al., 2000) . It is produced at high levels in the adult dentate gyrus (DG), where it facilitates learning and memory by stimulating the differentiation of neurons derived from NSCs of the DG subgranular neurogenic niche (Bath and Lee, 2010; Shimazu et al., 2006) . However, the potential role of NT-3 in the SEZ niche has not been investigated so far. In this work, we show that NT-3 expressed and released by endothelial cells of the brain vasculature supports quiescence and long-term maintenance of B cells in the SEZ. Furthermore, we demonstrate that B1 cells have access and respond to NT-3 produced by endothelia and delivered by the CSF. Mechanistically, NT-3 induces the rapid phosphorylation and activation of an endothelial isoform of nitric oxide (NO) synthase (eNOS) present in the NSCs themselves resulting in NO production and NO-dependent cytostasis.
RESULTS

NT-3 Promotes NSC Quiescence and Long-Term Maintenance
To evaluate the role of NT-3 in NSC behavior, and because Ntf3 null mice die immediately after birth, we analyzed the SEZ of 60-day-old (60-d) heterozygous Ntf3 +/lacZneo mice (CD1 genetic background), which express reduced levels of the neurotrophin (Figure S1A available online; Fariñ as et al., 1994 Fariñ as et al., , 1996 . Although we did not observe differences in the proportion of GFAP + cells (8.2 ± 0.6 versus a wild-type value of 10.1 ± 1.1%; n = 5), reduced amounts of NT-3 resulted in increased proportions of GFAP + cells that were also positive for the cell cycle-specific antigen Ki67 (17.0 ± 1.1% versus a wild-type value of 10.2 ± 0.7, n = 5; two-tailed Student's t test: p < 0.01). Analysis of cells exhibiting Nestin or Sox2 in combination with GFAP in mice that had been repeatedly injected with BrdU (seven times at 50 mg/kg of body weight, one injection every 2 hours) during the 12 hr period preceding euthanasia revealed a higher proliferative rate of GFAP + , GFAP + Nestin + , and GFAP + Sox2 + cells in heterozygous than in wild-type mice. Additionally, GFAP + cells that were positive for the cell cycle antigen Ki67 exhibited higher BrdU incorporation rates in mutant animals, suggesting that NT-3 slows down the cycling or delays the reentry into the cell cycle of activated B cells ( Figures 1A-1D ). Consistent with more activated B cells, Ntf3 heterozygous mice yielded more primary neurospheres than wild-types (Figure 1E and Figure S1B ), although they did not differ in size (sphere diameter in epidermal growth factor [EGF] + fibroblast growth factor [FGF] , in mm: 44.9 ± 3.1 in wild-types and 46.9 ± 1.8 in Ntf3 heterozygous mice, n = 6 independent cultures per genotype). Importantly, no changes in B cell proliferation or in the yield of primary neurospheres were found in postnatal 7-day-old mutants ( Figure 1E and Figures S1C-S1E) . Together, the data suggested that NT-3 plays a cytostatic role in the mature SEZ.
Higher numbers of neurospheres obtained from 60-day-old heterozygous mice were followed by a decline in primary neurosphere yield as the animals aged, starting at around 150 days and reaching a reduction of around 70% of the wild-type values by 240 days ( Figure 1E ), an indication that increased activity of B cells could be leading to their exhaustion. Again, lower numbers of neurospheres were not accompanied by changes in neurosphere diameter (40.1 ± 4.3 mm in wild-types and 40.0 ± 3.4 in Ntf3 heterozygous mice, n = 6). Activated NSCs can be detected in vivo based on their ability to retain nucleoside labels for more than 2 weeks (Maslov et al., 2004) and, in agreement with higher numbers of activated B cells, Ntf3 +/lacZneo young mice also had more cells that retained BrdU repeatedly injected 1 month before sacrifice (BrdU-labeling retaining cells or LRC), more GFAP + / Sox2 + LRC, and more LRC that were also Ki67 + ( Figures 1F-1H ). In contrast, we found significantly reduced proportions of LRCs at 240 days in Ntf3 heterozygous mice ( Figure 1H ). Because this could be the result of NSCs withdrawing from the cell cycle and engaging terminal differentiation, we stained for GFAP and S100b, a calcium-binding protein which is a marker of late astrocytic development and loss of stem cell potential (Raponi et al., 2007) . We found increased proportions of GFAP + cells that were also S100b + at 240 days relative to 60 days in Ntf3 heterozygous mice (Figures 1H and 1I) , indicating that B cells proliferate more actively and prematurely differentiate in animals with reduced levels of NT-3. The temporal pattern of hyperactivity followed by exhaustion of the B cell pool was accompanied by correlating changes in neuro/oligodendrogenic output. Increased activity of the GFAP + population in young Ntf3 heterozygotes resulted in higher numbers of Olig2 + newly generated oligodendrocytes (BrdUretaining cell progeny in the CC) and of newly generated neurons (BrdU-retaining cell progeny in the OB glomerular layer: 120 ± 1 versus a wild-type value of 85 ± 4 cells/mm 2 ; n = 4, p < 0.001; Figures 2A and 2B ), suggesting that NT-3 regulates the rate of production of B cell derivatives without apparent effects on fate choice. In the OB of Ntf3 heterozygotes versus wild-types, we found increased generation of glutamate decarboxylase (GAD67) + (111 ± 18 versus 64 ± 14), tyrosine hydroxylase (TH) + (36 ± 3 versus 25 ± 3), and GAD67 + /TH + (26 ± 3 versus 12 ± 2 cells/mm 2 ; n = 4, p < 0.05) periglomerular interneurons (Figures 2B and 2C) . Consistent with this increase, young Ntf3 heterozygous mice exhibited functional deficits in olfactory behavior reflected in higher detection thresholds ( Figure S1F ) and reduced discrimination of nonemotional odorants ( Figure 2D ), a result that is compatible with previous observations that an excess of inhibitory neurons results in olfactory discrimination deficits (Mouret et al., 2009) . However, at 240 days, both OB neurogenesis and oligodendrogenesis were significantly reduced in heterozygotes ( Figure 2E ). Together, these data indicate that the cytostatic effect of NT-3 is required for the quiescence and long-term maintenance of B cells and highlights the remarkable dosage effect in the action of this neurotrophin (Fariñ as et al., 1994) .
NT-3 Is Produced and Released by Endothelial Cells and Activates TrkC in NSCs
Analysis of b-galactosidase (b-gal) histochemistry in the forebrain of adult Ntf3 +/lacZneo mice (Fariñ as et al., 1996) was consistent with previous work (Vigers et al., 2000) and revealed high levels of NT-3 expression in neurons and astrocytes of different areas, including the olfactory cortex, septum, hippocampus, or the nucleus of the stria terminalis ( Figure S2A ). In contrast, we did not observe any obvious X-gal staining in the SEZ of Ntf3 +/lacZneo mice ( Figure 3A ). More in-depth analysis at high Figure S2B ). In line with the presence of b-gal in blood vessels, we detected NT-3 with ELISA in cell lysates and conditioned media of primary CD31 + endothelial cells (BECs)
acutely isolated from adult mouse brains (Andjelkovic et al., 2003) . We could also detect NT-3 protein in choroid plexus (CP) homogenates and, more interestingly, in CSF directly isolated from the cisterna magna of adult mice (Liu and Duff, 2008; Figures 3D and 3E) . NT-3, but not b-gal protein could be readily detected by immunohistochemistry in ependymal cells lining the ventricle and in GFAP + B1 cells, both in sections and in SEZ whole-mounts in which uniciliated B1 cells can be positively identified by double immunostaining for basal cilia marker g-tubulin and GFAP . Because the antibodies to NT-3 were specific, as tested in Ntf3 null fetal brain tissue (Figures S3A and S3B) , these data suggested that B1 cells do not produce, but take up the neurotrophin and that vascular NT-3 could be acting as an endothelial niche and CSF regulator of NSC behavior. Subependymal GFAP + cells had immunodetectable levels of TrkC and TrkB, but not TrkA, and neurosphere cultures expressed TrkC, but not NT-3 ( Figures 3G-3I and Figure S3C ). Treatment of neurospheres with human recombinant NT-3 for 5 min induced the phosphorylation of its cognate receptor TrkC ( Figure 3J ). Moreover, exogenous addition of NT-3 to cultures of isolated NSCs reduced neurosphere formation, without affecting cell survival or neurosphere size (52.4 ± 3.1 mm versus 51.3 ± 2.8 in NT-3-treated cultures; n = 6), and the reduction was rescued by addition of a blocking TrkC antibody ( Figure 3K and Figure S3D ). Medium conditioned by BECs induced increased formation of neurospheres as described previously (Shen et al., 2008) , but addition of the TrkC antibody further increased the yield ( Figure S3E ), indicating that NT-3 released by endothelial cells inhibits proliferation through TrkC.
Endothelial NT-3 Regulates Quiescence of NSCs
To test whether brain endothelial NT-3 regulates NSC quiescence in vivo, we crossed mice carrying loxP sites flanking the Ntf3 exon ( In line with this, we could still detect NT-3 in brain areas with neuronal expression such as the hippocampus, but not in CD31 + cells or in BECs isolated from the deleted mice ( Figures  S4G-S4I ). Likewise, we could not detect NT-3 with ELISA in CP homogenates and CSF directly obtained from Ntf3-Tie2ko mice ( Figure S4H ), demonstrating that NT-3 produced and released by endothelial cells in the CP is taken up by the choroid epithelium through absorptive endocytosis and undergoes transcytosis to be released into the CSF, as described for other proteins (Balin and Broadwell, 1988; Strazielle and Ghersi-Egea, 2013) . This together with the abrogation of NT-3 immunodetection in ependymal cells lining the ventricle and in subependymal GFAP + cells in Ntf3-Tie2ko mice ( Figure S4J ) further indicated that endogenous NT-3 acting on B1 cells is provided by endothelial cells, either directly from irrigating blood vessels or via CSF.
Although the Tie2 promoter becomes activated during fetal development and the lack of vascular NT-3 results in partial embryonic lethality, as in Ntf3 nulls (Donovan et al., 1996 ; (legend continued on next page) Figure S4K ), no changes in proliferation were observed in the SEZ of surviving Ntf3-Tie2ko versus control mice at early postnatal stages ( Figure S4L ). However, GFAP + cells of the mature SEZ were proliferating more actively in Ntf3-Tie2ko (F) Number of neurospheres formed in cocultures with Ntf3-Tie2ko or control BECs, with and without exogenous NT-3 or L-NAME. DAPI was used for nuclear staining. *p < 0.05; **p < 0.01; Scale bars represent 10 mm in (A), (C), and (E); for inset in (C), 5 mm. Error bars represent mean ± SEM.
mice ( Figures 4A and 4B ), as they were in Ntf3 heterozygous mice, and apparently had more Ki67 + /GFAP + B1 cells next to vascular elements ( Figure 4C ). Primary sphere yield was also significantly higher when cells were dissociated from the SEZ of 60-day-old Ntf3-Tie2ko versus control mice ( Figure 4D ). These data together indicated a functional effect of endothelial NT-3 in NSC proliferation. To further demonstrate the functional effects of NT-3, we established indirect cocultures of NSCs with different NT-3-expressing endothelia, such as venous endothelial cells derived from human umbilical cords (hUVECs), as well as primary BECs and aortic rings (AR) isolated from our mice (Figures S5A-S5E ). AR were cultured as previously described (Aplin et al., 2008) ; a dense rich layer of different cell types migrated outward from the ring, including CD31 + endothelial cells that took up fluorescent acetylated low-density lipoprotein (Dil-Ac-LDL) and formed tubular vessel structures ( Figure S5B ). Supporting our in vivo results, we found higher numbers of neurospheres in cocultures of NSCs with wild-type BECs and AR or with hUVECs if NT-3 blocking antibodies were added to the cocultures ( Figure 4E and Figures S5F and S5G) Figure S5H ). These data identified endothelia as a natural source of NT-3 controlling NSC cycling.
** *
Cytostatic Effects of Endothelial NT-3 Are Mediated by Increased NO Production in NSCs
We next investigated the mechanism underlying this unprecedented role of NT-3 in NSC quiescence. NO is synthesized by the enzyme NOS that catalyzes the conversion of L-arginine and oxygen into citrulline and second messenger NO. Three different NOS isoforms have been identified in mammals: constitutive neuronal NOS (nNOS; encoded by the Nos1 gene) and endothelial NOS (eNOS; Nos3), and inducible NOS (iNOS; Nos2; Fukumura et al., 2006) . NT-3 reportedly modulates the level and/or activity of eNOS in rat brain and pulmonary vasculature (Meuchel et al., 2011; Takeo et al., 2003) . To analyze whether production of NO could be mediating the effects of NT-3 on NSCs, we first used a pharmacological approach with constitutive NOS competitive inhibitor L-NAME (Rees et al., 1990) and nNOS specific inhibitor SMTC (Furfine et al., 1994) . Treatment with L-NAME increased neurosphere formation in cocultures of NSCs with AR and rescued the reduction caused by addition of exogenous NT-3; in contrast, SMTC had no effects in either the presence or the absence of exogenously added NT-3, suggesting that nNOS was not involved ( Figure S6A ). Likewise, treatment with L-NAME increased neurosphere formation in coculture experiments with BECs isolated from control, but not Ntf3-Tie2ko mice ( Figure 4F ), suggesting a model in which NO produced by eNOS in response to vascular NT-3 regulates quiescence in the perivascular niche. We next used a genetic approach by performing cocultures with NSCs and BECs isolated from adult Nos3 mutant and wild-type mice (Huang et al., 1995) . Neurosphere formation by wild-type NSCs was similar, independently of the BECs genotype; more intriguingly, neurosphere formation was increased in both conditions following treatment with L-NAME, suggesting that the observations were not the result of eNOS inhibition in endothelial cells. Notably, in the complementary experiments with Nos3 wild-type and mutant NSCs in coculture with wildtype BECs, more neurospheres were produced by eNOSdeficient NSCs, even in the absence of L-NAME ( Figure 5A ). Together, these data suggested the possibility that NSCs contained an endothelial form of NOS that was relevant for the observed phenotype in vitro. Indeed, the expression profile for NOS isoforms in NSCs was similar to that of endothelial cells and we found detectable levels of mRNA and protein for eNOS, but not nNOS in cultured NSCs ( Figure S6B ). Moreover, eNOS could be readily immunodetected in SEZ GFAP + cells and irrigating capillaries, whereas nNOS immunoreactivity was confined to neurons . Remarkably, GFAP + mature astrocytes within the adjacent striatal parenchyma ( Figure 5B ) or other brain areas (not shown) did not contain immunodetectable levels of eNOS. The data indicated that the predominant NOS enzyme in SEZ neurogenic astrocytes is the endothelial isoform.
Because NSCs expressed eNOS, we next determined whether NT-3 could regulate NO production in these cells. Treatment with NT-3 significantly increased the level of eNOS phosphorylation in both aorta and neurosphere cultures ( Figure 5D and Figure S6F ) and eNOS phosphorylation was reduced in SEZ homogenates of Ntf3 heterozygous mice ( Figure 5D ). Furthermore, neurospheres cultured in medium conditioned by Ntf3-Tie2ko BECs showed lower levels of phosphorylated eNOS ( Figure 5D ). Direct monitoring of NO production with the specific fluorescent probe DAF-2 (Zhou and He, 2011) indicated increased production in neurospheres treated with NT-3 or cultured in BEC-derived conditioned media, and the signal could be reduced by treatment with L-NAME . To test the potential role of NO produced by NSCs themselves, we cultured isolated NSCs in the presence of exogenously added NT-3 and/or L-NAME. Indeed, the NOS inhibitor rescued the deficit in neurosphere formation induced by NT-3 ( Figure 5H ). Moreover, although treatment with NT-3 induced the phosphorylation of the receptor TrkC to similar levels in Nos3 wild-type and mutant NSC cultures, the number of neurospheres formed in the presence of the neurotrophin was reduced in the wild-type, but not in the mutant cultures ( Figures 5H and 5I ). Our data suggested that increased eNOS activity in NSCs themselves could account for NT-3 cytostatic effects. 
CSF-Distributed NT-3 Instructs Quiescence in Adult NSCs through eNOS Activation
Our results indicated the presence of high quantities of endothelia-derived NT-3 in the CSF and, therefore, B1 cells could be exposed to NT-3 released by adjacent endothelial cells or present in the lateral ventricle. It has been proposed that B1 cells can access molecules present in the CSF through receptors present at the membrane of their primary cilium (Falcã o et al., 2012) . To test whether B1 cells could indeed take up NT-3 from the CSF, and because reliable assessment of the presence of specific receptors at the primary cilium membrane is technically difficult, we biotinylated human recombinant NT-3 which was then stereotaxically injected (as a single dose of 100 ng) into the lateral ventricle and later detected with fluorescent streptavidin in sections of mice perfused 30 min or 3 hr after the injection ( Figure 6A ). Compared to control mice injected with nonbiotinylated NT-3, which did not reveal any fluorescent signal ( Figure 6B ), we could detect the labeled neurotrophin in the SEZ. The signal was restricted to the first few 10-20 mm from the ventricle lumen after either 30 min or 3 hr. Moreover, the signal was discrete and virtually always colocalized with the immunodetection of S100b in the cytoplasm of cells immediately adjacent to the lumen and with GFAP in subependymal cells. Remarkably, cells containing biotinylated NT-3 that were most distant to the ventricle were always GFAP + ( Figure 6C and Figure S7A ). These data indicated that B1 cells have access to CSF-delivered NT-3 and suggested that this access might be due to receptor-mediated transport rather than intraparenchymal passive diffusion.
To functionally address the relevance of the CSF compartment, we next evaluated whether B1 cells can respond to CSF-borne NT-3 in the absence of direct endothelial sources by infusing the neurotrophin into the lateral ventricles of Ntf3-Tie2ko mice during 7 days, at a rate of 100 ng/day. Infusion in mice lacking endothelial NT-3 did not change the size of the GFAP + population of subependymal cells, but reduced their BrdU-incorporation rate to wild-type values ( Figures 6D and  6E) . Together, these results indicated that B cells can take up NT-3, most likely through receptors present in their cilia, and that this NT-3 can regulate their cycling/quiescence in a direct way.
Our in vitro data indicated that the NT-3 effects on quiescence were mediated by activation of the eNOS enzyme leading to NO production in NSCs themselves. We, therefore, decided to test the implication of the eNOS isoform present in B1 cells in response to intraventricular NT-3. The SEZ phenotype of Nos3 mutant mice has been reported following experimental stroke, but not under normal conditions (Chen et al., 2005) . Despite no significant changes in blood vessel morphometrical parameters such as tube diameter or length, we found that the SEZ of 60-day and 240-day mutant mice was less irrigated than that of wild-types under normal conditions, but we could obtain yields of primary neurospheres similar to those from wild-type SEZs (Figures S7B-S7F) . Therefore, we decided to infuse NT-3 or saline into the lateral ventricle of Nos3 wild-type and mutant 60-day mice. We did not find differences in the number of GFAP + cells or in their proliferation rate in vehicle-infused
Nos3 mutant mice compared wild-type littermates (Figures 6F and 6G) . We did, however, decrease the proliferation of B1 GFAP + cells in the wild-type but not in the eNOS-deficient mice when NT-3 was infused ( Figures 6F and 6G ), an indication that eNOS present in B1 cells could be mediating NT-3 actions on quiescence also in vivo. Interestingly, and despite a lack of apparent effects of the Nos3 targeted mutation on B cells in young animals, 240-day eNOS-deficient mice exhibited reduced numbers of subependymal BrdU-LRC in general and within the population of GFAP + and GFAP + Sox2 + cells ( Figure S7G ), suggesting that eNOS is also required for the maintenance of NSCs in the SEZ.
DISCUSSION
Recent studies have highlighted that SEZ stem cells and derived progeny are intimately associated with blood vessels and that subependymal B1 cells can access proteins in the CSF through specific receptors present at their primary cilium membrane (Falcã o et al., 2012; Hjelmeland et al., 2011; Shen et al., 2008; Tavazoie et al., 2008) . However, direct or CSFdelivered vascular signals involved in supporting quiescence and long-term maintenance of NSCs had not been identified.
Our data support a model in which B1 cell quiescence can be modulated by NO production in an autocrine manner in response to NT-3 produced only by endothelia. NT-3 is in SEZ irrigating blood vessels and ventricular CSF, and B1 cells have regulated access to both compartments. Moreover, proliferative activity of B1 cells appears to be related to the level of NT-3 available. Reductions of NT-3 lead to increased B1 cell cycling, whereas experimental addition of NT-3 to the CSF reduces proliferation, suggesting that this signal plays an active role in instructing quiescence in a dose-dependent manner. These results provide novel insights into the interaction of adult NSCs with their niche, and describe a mechanism of NSC cycling regulation that requires a directional signaling from endothelial sources. Quiescence control has important implications in the maintenance of adult stem cells. Genetic lineage tracing studies have indicated that division-coupled terminal differentiation of normal NSCs to a nonmultipotent mature astrocyte unavoidably leads to a reduction of the stem cell pool in the DG subgranular zone (Encinas et al., 2011) . Moreover, mutations that disrupt quiescence and drive adult stem cells into active constitutive proliferation, such as mutations in genes coding for p21, result in stem cell hyperproliferation followed by loss of stem cell potential and depletion of pluripotent stem cell pools (see Porlan et al., 2013) . Sustained reductions in the levels of NT-3 leads to exhaustion of the potential to produce neurospheres and GFAP + cells appear to differentiate into mature S100b + astrocytes. CSF is a complex and dynamic fluid with an important role in the distribution of signaling molecules to the brain and the CP barrier can actively regulate the availability of somatic sources of CSF-distributed soluble cues to brain cells, including B1 cells (Strazielle and Ghersi-Egea, 2013 ). It will be interesting to determine how this barrier controls the availability of NT-3 to B1 cells under different conditions, including aging. The effects of neurotrophins in adult neurogenesis have been investigated in recent years. Despite a relatively high number of works analyzing the effects of BDNF and its signaling receptor TrkB in the dynamics of the postnatal and adult SEZ, their potential effects are still unclear. Most data appear to support, however, an action of BDNF in the survival of neuroblasts (reviewed in Bath and Lee, 2010) . As for NT-3, it has only been shown that loss of NT-3 negatively affects the survival and proliferation of SEZderived oligodendrocytes and promotes differentiation of DG newly generated neurons (Kahn et al., 1999; Shimazu et al., 2006) . This is the first study showing that NT-3, or any other neurotrophin, influences B1 cell maintenance through actions on quiescence. Interestingly, our findings indicate that the molecular mechanism underlying NT-3 cytostatic effect on adult NSCs implicates the production of NO through fast modulation of eNOS, but not nNOS in the NSCs themselves. Fetal and early postnatal NSCs had been shown to express eNOS (Li et al., 2006; Wang et al., 1999) . However, NT-3 effects appear restricted to the mature SEZ and the lack of phenotype in the SEZ at early postnatal ages that we describe here fully agrees with previously reported data indicating that NT-3 is dispensable for OB neurogenesis during embryogenesis (Nef et al., 2001) .
NO regulates many physiological processes through the NO/ cGMP pathway, as well as through protein S-nitrosylation (Fukumura et al., 2006) . NO can induce growth arrest in neural progenitors, promoting their differentiation (Cheng et al., 2003; Peunova and Enikolopov, 1995) . In the adult brain, a dual role of this second messenger, either promoting or inhibiting proliferation of neuronal precursors, has been reported. NO produced by nitrergic neurons suppresses adult neurogenesis under physiological conditions. NO inhibition augments neurogenesis in adult germinal areas by promoting cell division without affecting programmed cell death, and the same effect is observed when nNOS is inactivated, albeit it had not been determined yet whether NO signaling participates in the maintenance of NSC quiescence (Cheng et al., 2003; Moreno-Ló pez et al., 2004; Packer et al., 2003) . Interestingly, it has been shown that constitutive NOS blockade by L-NAME increases proliferation to a much larger extent than inactivating mutations of nNOS (Cheng et al., 2003; Moreno-Ló pez et al., 2004; Packer et al., 2003) , an observation fully consistent with our reported implication of eNOS in the regulation of subependymal NSC cycling. In contrast to NO inhibitory effects during physiological conditions, vasculature-derived NO can promote neuronal production during ischemic insults (Cheng et al., 2003; Hjelmeland et al., 2011; Moreno-Ló pez et al., 2004; Packer et al., 2003; Zhang et al., 2001; Zhu et al., 2003) . In addition, brain tumor stem-like cells are often found in close contact with tumor vascular endothelia expressing elevated levels of eNOS (Calabrese et al., 2007; Iwata et al., 1999) . Indeed, it has been recently shown that NO promotes Notch signaling in PDGF-induced glioma cells, increases their capacity to produce neurospheres, and enhances their tumorigenic capacity in vivo (Charles et al., 2010) . All these data reveal a complex scenario where production of NO may condition the stem cell niche in different ways. In this context, our data indicate specific effects of NO, possibly in a cell-autonomous manner, in the quiescence and maintenance of adult NSCs.
NSCs reside and proliferate in vascularized niches. Moreover, they exhibit a characteristic morphology that allows them to be exposed to signals derived from endothelia of the irrigating vascular network and to signals present in the CSF. NSCs appear endowed with the capacity to produce NO by activation of an eNOS and the resulting NO can act as a cytostatic signal. However, the activation of NO production requires the presence of NT-3, which is not produced, but taken up by NSCs (Figure 7) . It is likely that the production of NT-3 by vascular sources creates a specific requirement for NSCs to proliferate in perivascular/ periventricular niches.
EXPERIMENTAL PROCEDURES Animals and In Vivo Manipulations
and Nos3 (B6. 129P2-Nos3tm1Unc/J) mice were obtained from The Jackson Laboratory and genotyped as described (Huang et al., 1995; Kisanuki et al., 2001; Shimazu et al., 2006) . Housing and experiments were carried out following protocols approved by the ethics committee of the Universidad de Valencia. Mice were injected intraperitoneally with 50 mg/kg of BrdU every 2 hr for 12 consecutive hours (seven injections in total) and killed 1 hr or 30 days after the last injection. Ten micrograms of recombinant human NT-3 (PeproTech) was biotinylated using EZ-LinK Sulfo-NHS-Biotinylation (Thermo Scientific), following instructions of the manufacturer, and buffer exchange was performed with Zeba Spin Desalting Columns, 7K MWCO (Thermo Scientific). Efficient biotinylation was tested by dot-blot with peroxidase-conjugated neutrAvidin (Molecular Probes). For delivery, mice were anesthetized and fixed to a stereotaxic device (NeuroLab) and 1 ml NT-3 b (100 ng/ml) was injected into the lateral ventricle of the mice with a Hamilton syringe. Mice were perfused 30 min or 3 hr after the injections and processed for detection with tetramethylrhodamine-conjugated neutrAvidin (Molecular Probes) in vibratome sections. For infusions, infusion kit 3 cannulas attached to osmotic mini-pumps (Alzet, model 1007D; flow rate 0.5 ml/h; Ferron et al., 2007) and loaded with recombinant human NT-3 (8.4 ng/ml; 100 ng/day) or saline were inserted into one lateral ventricle. Stereotaxic coordinates for intraventricular injections/infusions were (millimeters from the bregma): anterior-posterior, À0.3; mediolateral, À0.8; and dorsoventral, À3 from the skull surface.
Behavioral Tests
For threshold detection, mice were placed in a 22.5 3 22.5 cm open Plexiglas box with solid light green walls and approximately 1 cm of wooden chip bedding. After 3 min of free exploration, a cotton stick soaked in mineral oil was introduced into the box through a 1-cm hole located 8 cm above the floor and 11.2 cm from the corner. The stick was held in place for 1 min and thereafter substituted by a series of five consecutive fresh cotton sticks soaked also in nonodorant mineral oil to produce habituation to the novel object. Mice were then exposed to successive cotton sticks with increasing concentrations of citralva (3,7-dimethyl-2,6-octadiene-1-nitrile; Ventó s SA; from 1:160 to 1:10) diluted in mineral oil. For the habituation-dishabituation test, the six trials with mineral oil were followed by six trials of geraniol (terpene geraniol; Ventó s SA, Barcelona) and six trials of citralva, at 1:20. We used a digital video system to record the olfactory exploration, including smelling, sniffing, heading toward the cotton stick, approach (2-3 cm) or contact, and tracking evaluation software (Smart Junior, Panlab S.L., Harvard Apparatus). After each test, the olfactory exploration box was thoroughly wiped clean with 5% alcohol and dried.
Immunohistochemistry and b-Galactosidase Histochemistry Embryos were fixed by immersion in 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer pH 7.4 (PB) for 4 hr and mice were first deeply anesthetized and then perfused transcardially with 4% PFA in PB. Fixed brains were sectioned with a vibratome (Leica VT1000) at 25 mm. Sections were incubated in 10% fetal bovine serum (FBS) and 0.1% Triton X-100 in PB for 1 hr, and overnight in primary antibodies (Table S1A) . For BrdU detection, sections were first incubated in 2M HCl for 20 min at 37 C and neutralized in 0.1M sodium borate (pH 8.5). Detections were performed with fluorescent secondary antibodies (Table S1B) . Biotinylated IB4 lectin (1:100; Sigma) was detected with Cy3-conjugated streptavidin (1:300; Jackson Immuno-Research Laboratories).
For SEZ whole mounts, we used protocols established previously (Mirzadeh et al., 2008) . Briefly, the lateral ventricle walls were dissected out and fixed for 1.5 hr in 4% PFA in PB and washed overnight at 4 C in PB. Whole mounts were washed three times in PB containing 2% Triton X-100 for 15 min each, blocked for 2 hr in 10% FBS and 2% Triton X-100 in PB, then incubated with primary and secondary antibodies in the same blocking solution for 48 hr each at 4 C. Fluorescent samples were mounted with Fluorsave (Calbiochem), and 4 0 ,6-diamidino-2-phenylindole (DAPI; 1 mg/ml, 5 min) or Sytox Green (1:1,000; Molecular Probes) were used for counterstaining. Samples were analyzed with Leica Microsystems Multispectral and Olympus FV10 confocal microscopes. To score numbers of cells in the SEZ we analyzed series of five 25-mm-thick vibratome sections 600 mm apart at AP coordinates 1.10, 0.86, 0.62, 0.38, and 0.14, covering the extent of the SEZ between 1.70 and À0.02. Confocal microscopy images were taken at 1003 magnification. Every region of interest had a z stack of 20 mm, with optical sections every 1 mm. Quantifications were made in three different levels of every z stack ensuring no double counting. OB counts were done in series containing six or seven sections 300 mm apart between AP coordinates 4.5 and 3.5. Confocal images of the entire glomerular layer were obtained at 603 magnification in every section. At least 17 fields were analyzed in each slice and the glomerular area was measured to determine density. For X-gal histochemistry, brains were fixed by immersion in 4% PFA in PBS at pH 7.4 with 2 mM MgSO4 and 5 mM EGTA for 30 min at 4 C and processed for vibratome sectioning.
Sections were incubated in PBS with 2 mM MgCl2, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 0.01% sodium deoxycholate, 0.02% NP-40, and 1 mg/ml X-Gal for 24 hr and counterstained with nuclear fast red.
Cell and Organotypic Cultures
Methods for NSC culture, neurosphere formation analysis, viability measurements, and BrdU immunocytochemistry have been described (Ferron et al., 2007) . Primary spheres were counted and their diameters measured after 5 days in vitro and established neurosphere cultures were always analyzed at passage 5. For passages, neurospheres were treated with Accutase (0.5 mM; Sigma) for 10 min, mechanically dissociated to a single-cell suspension, and replated in growth medium containing EGF and fibroblast growth factor, supplemented or not with human recombinant NT-3 (20 ng/ml; PeproTech). NOS pan-inhibitor N G -nitro-L-arginine methyl ester (L-NAME, Sigma; Rees et al., 1990) or the inhibitor nNOS S-methyl-L-thiocitrulline (SMTC, Sigma; Furfine et al., 1994) were used at 100 mM and 1 mM, respectively. Blocking rabbit IgGs to NT-3, to TrkC and nonrelevant IgGs (Santa Cruz Biotechnology) were used at 3 mg/ml. hUVEC and media were from AdvanCell. BECs were obtained as previously described (Andjelkovic et al., 2003) with modifications. Briefly, brains from 60-day-old mice were minced in Hanks balanced salt (HBSS; Invitrogen) and homogenized gently with a 21G needle syringe. The microvessels were cleaned from myelin using an 18% dextran solution (in MEM with HEPES and A/A; GIBCO) and separated from erythrocytes by centrifugation at 9, 000 3 g for 10 min. The microvessels were digested in HBSS containing 1 mg/ml collagenase/dispase (Roche) for 1 hr at 37 C. BECs were plated on rat-tail extracted collagen and cultured in endothelial cell growth medium MV2 (Ready-to-use; Promocell). Aortas were dissected free of periaortic fibro-adipose tissue and sectioned transversally into 1-mm rings, which were embedded in Matrigel matrices (BD Bioscience) and cultured in MV2 (Aplin et al., 2008) . AR cultures were incubated at 37 C for 5 days with 1,1-dioctadecyl-3,3,3,3-tetramethyl-indocarbocyanine-labeled acetylated low-density lipoprotein (DiI-Ac-LDL; Molecular Probes) at 5 mg/ml and then fixed with 4% PFA for 20 min. The medium was replaced every 48 hr and the vessels were allowed to form for 5 days. For coculture experiments, MV2 medium was replaced by neurosphere growth medium, a transwell insert (0.4-mm pore, Millipore) was placed above after 2 hr, and dissociated neurosphere cells were seeded in the upper compartment at a 2.5 cell/ml density. Neurosphere formation was analyzed after 5 days.
NO Production Assay
The NO-sensitive membrane-permeable fluorescein-based chromophore diaminofluorescein diacetate (DAF-2 DA; Calbiochem) reacts with NO to form a benzotriazole product, which emits in the fluorescein emission range and can be used to monitor the production of NO in living cells (Zhou and He, 2011) . Neurospheres and whole aortas/AR were seeded on Matrigel, loaded with 10 mM of DAF-2 and kept at 37 C for 45 min. Fluorescence images were captured at different time points using an Olympus FV10 confocal microscope. At least 50 spheres were analyzed for each condition in neurosphere cultures. NO was measured in portions comprising the entire width of the vessel, from the adventitia to the endothelium. Because the vessel wall exhibited the characteristic basal fluorescence of elastin fibers, this was deducted from the quantification. Hoechst fluorescence was used as a control. Quantification of fluorescence intensities was performed using the software Microimage from Olympus.
Immunoblot, Immunoprecipitation, and ELISA Cells and tissues were lysed in sodium dodecyl sulfate (SDS)-buffer (25 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1% SDS), supplemented with phosphatase and protease inhibitors. Approximately 30 mg of protein extract was resolved with SDS-PAGE. For immunoprecipitations, $10 7 cells were split in two and treated or not with 20 ng/ml NT-3 for 10 min, collected on ice in PBS supplemented with sodium orthovanadate, and lysed in 25 mM Tris-HCl, pH 7.4, 150 mM NaCl, Triton X-100 1% and 1 mM EDTA supplemented with phosphatase and protease inhibitors. Lysates were incubated overnight with 3 mg of anti-pTyr antibody (clone 4160; 1:500; Millipore) and Dynabeads protein G (Invitrogen) was used to retrieve the immunoprecipitates. Beads were incubated with Laemmli buffer and separated from the samples using a magnet.
Immunoprecipitates were resolved in 4%-15% Criterion TGX Precast Gel (Bio-Rad) and transferred to nitrocellulose membranes (Protran Sigma). Membranes were blotted with primary (Table S1 ) and secondary peroxidaseconjugated antibodies (1:5,000; Dako) and reacted by chemiluminiscence (Western Lighting Perkin Elmer). Membranes were stripped off the first antibodies using 200 mM glycine pH 2.5, 0.02% SDS, and reblotted as specified. Films were scanned and band density quantitated with Image J software. NT-3 protein levels were measured with ELISA using the NT-3 Emax Immunoassay System Kit specific for mouse NT-3 (Promega) according to the manufacturer's protocol. For measurements in serum-free conditioned media and cell lysates, BECs were grown for 2 days and CPs were acutely isolated. Cell/tissue samples were lysed with 20 mM Tris-HCl pH 8.0, 137 mM NaCl, 1% NP40, 10% glycerol, 1 mM PMSF, 10 mg/ml aprotinin, 1 mg/ml leupeptin, and 0.5 mM sodium vanadate, and total protein concentration was determined using a BCA Kit (Pierce). CSF was collected using a glass capillary tube with an inner diameter of $0.5 mm through a puncture in the cisterna magna of adult mice, as previously described (Liu and Duff, 2008) . Serial dilutions of recombinant mouse NT-3 were used to calibrate the assay and ensure that experimental samples were within the linear range of detection.
Resultant measurements of NT-3 (pg/ml) were normalized to total milligrams of protein.
RNA Isolation and Expression Analysis
RNAs were extracted with RNeasy MicroKit (QIAGEN) and 1 mg of RNA was reverse-transcribed into cDNA using random primers and SuperScript II RT reverse transcriptase (Invitrogen) in the presence of first strand buffer (50 mM Tris-HCl, 75 mM KCl, 3 mM MgCl 2 ), 5 mM dithiothreito, and 0.25 mM each of dNTPs (Amersham) for 2 hr at 42 C. One microliter of the reverse-transcribed RNA was amplified by PCR with appropriate primers (Table S2A) . Quantitative PCR was performed by real-time PCR in a DNA Engine 2 Opticon detection system (Bio-Rad) using SYBR green I as a double-strand DNA-specific binding dye. Thermocycling was performed in a final volume of 20 ml containing 2 ml of cDNA sample (diluted 1:5), 20 pmol of each primer (Table S2A) , 2 mM MgCl 2 , 0.2 mM dNTP mixture, 1X Taq reaction buffer, 0.5 U HotStart Taq DNA polymerase, and 0.5 ml of a 1:3,000 dilution of SYBER green I. For Ntf3 and Gapdh (as endogenous control) detection, Taqman probes were used (Table S2B ) and reactions were performed in a
Step One Plus cycler with Taqman Fast Advanced Master Mix (Applied Biosystems).
Statistical Analysis
All statistical tests were performed using SPSS software (version 13.0; SPSS). The significance of the differences between groups was evaluated in all experiments by a one-way ANOVA followed by a Tukey post-hoc test. For behavioral studies, a two-way ANOVA was run followed by Tukey or Bonferroni post-hoc test. When comparisons were performed with relative values (normalized values and percentages), data were first normalized using an arcsen transformation. Values of p < 0.05 were considered statistically significant. Data are always presented as the mean ± SEM, and the number of experiments performed with independent cultures/animals (n) is indicated.
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